| Quantity: | |
|---|---|
【COMPOSITION AND CONTENT】
This product contains inactivated Newcastle Disease Virus Strain La Sota with a viral titer of no less than 4×10⁸·⁰ EID₅₀ per 0.1 ml before inactivation; inactivated Avian Infectious Bronchitis Virus Strain M41 with a viral titer of no less than 4×10⁶·⁵ EID₅₀ per 0.1 ml before inactivation; inactivated Avian Egg Drop Syndrome Virus Strain HE02 with a viral titer of no less than 4×10⁶·⁰ TCID₅₀ per ml before inactivation; and inactivated H9 Subtype Avian Influenza Virus Strain HN106 with a viral titer of no less than 4×10⁷·⁰ EID₅₀ per 0.1 ml before inactivation.
【CHARACTER】
Milky white emulsion.
【INDICATIONS】
For the prevention of chicken Newcastle disease, avian infectious bronchitis, egg drop syndrome and H9 subtype avian influenza in chickens. The immune duration lasts 5 months.
【DOSAGE AND ADMINISTRATION】
Administer via subcutaneous injection at the neck or intramuscular injection. For laying hens and breeding chickens 2 to 4 weeks before the start of laying, 0.5 ml per chicken.
【PRESENTATION】
100 ml/bottle, 250 ml/bottle, 500ml/bottle
【STORAGE AND SHELF LIFE】
Store at 2–8 °C. Shelf life: 12 months from the date of manufacture.
For use only under veterinary supervision.
Four-disease integrated prevention simplifies immune procedures: One shot prevents four core high-incidence poultry diseases, replacing multiple single or combined vaccines. It reduces vaccination times and immune stress, cuts labor and epidemic prevention costs, and fits standardized immunization procedures for layers and breeders.
Ultra-high quadruple antigen titer for stable and reliable protection: Adopts high-standard four-strain compound formula with sufficient antigen content for each component. It induces uniform and high-level protective antibodies with strong immunity and stable batch quality.
Pre-laying targeted immunization stabilizes laying performance: Designed for immunization 2–4 weeks before laying, it builds a complete immune barrier in advance, effectively avoiding production decline, poor egg quality and sporadic deaths caused by four major diseases during the peak laying period.
Zero-stress and high-safety formulation without production impact: The uniformly milky emulsion adopts thorough inactivation technology with high purity and low irritation. No visible adverse reactions occur after standard vaccination, ensuring normal feeding, growth and stable laying performance of chickens.
Stable formulation and efficient on-site operation: The emulsion is stable and not easy to delaminate. It only needs room temperature recovery and shaking before use. Dual inoculation methods adapt to large-scale batch vaccination with high efficiency.
Q: What type of vaccine is this? What diseases does it prevent?
A: This is a quadruple inactivated vaccine for Newcastle disease, infectious bronchitis, egg drop syndrome and H9 subtype avian influenza, a non-prescription veterinary drug, specially used to prevent the four high-incidence poultry diseases.
Q: What are the applicable chickens, vaccination method and dosage?
A: Applicable to healthy layers and breeders 2–4 weeks before laying. Administer via neck subcutaneous or intramuscular injection at a fixed dosage of 0.5mL per chicken, fitting the standardized pre-laying immunization procedure.
Q: How long is the immune protection period after standard vaccination?
A: The immune duration lasts up to 5 months after standard vaccination, fully covering the key laying cycle of layers and breeders and stably protecting egg production performance from four diseases.
Q: What are the core operation specifications before vaccine use?
A: Only healthy chickens are suitable for vaccination. Warm to room temperature and shake fully before use. Do not use demulsified or deteriorated vaccines. Sterilize inoculation appliances and injection sites strictly in advance, and use up the opened vaccine on the same day.
Q: What are the specifications, storage conditions and shelf life of the vaccine?
A: Three mainstream specifications (100mL/250mL/500mL) are available. Store at 2～8℃ away from light with a shelf life of 12 months, suitable for daily reserve and centralized immunization of large-scale layer and breeder farms.
Q: What are the strict taboos for vaccine storage and transportation?
A: Store and transport at 2～8℃ away from light. Freezing is strictly prohibited, which will destroy the emulsion structure and cause vaccine failure. Demulsified vaccines are forbidden for use.
Q: How to dispose of vaccine wastes in a standardized way?
A: All wastes such as residual vaccine, used vaccine bottles and inoculation appliances must be uniformly collected and harmlessly disposed of to eliminate biosafety hidden dangers.
